SAVIENT PHARMACEUTICALS INC: cashflow_financing

Value{"amount": 5844000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2010-01-01 – 2010-09-30
Statuscurrent
EntitySAVIENT PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000930413-10-005502 · Open the official SEC filing →
Retrieved: 2026-08-19T07:42:09.071666+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000722104/cashflow-financing/2010-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/10ca6fb4-66d8-4efa-876b-995780bbc288

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies